These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 1677039

  • 1. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
    Schoffelmeer AN, Warden G, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):237-42. PubMed ID: 1677039
    [Abstract] [Full Text] [Related]

  • 2. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN, Yao YH, Gioannini TL, Hiller JM, Ofri D, Roques BP, Simon EJ.
    J Pharmacol Exp Ther; 1990 Apr 01; 253(1):419-26. PubMed ID: 2158552
    [Abstract] [Full Text] [Related]

  • 3. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1988 Sep 01; 246(3):1018-25. PubMed ID: 2843623
    [Abstract] [Full Text] [Related]

  • 4. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    Schoffelmeer AN, De Vries TJ, Hogenboom F, Hruby VJ, Portoghese PS, Mulder AH.
    J Pharmacol Exp Ther; 1992 Oct 01; 263(1):20-4. PubMed ID: 1328606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY, Yang HH, Li S, Adams JU.
    J Pharmacol Exp Ther; 1995 Jun 01; 273(3):1047-56. PubMed ID: 7791074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Jun 01; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN, Rice KC, Jacobson AE, Van Gelderen JG, Hogenboom F, Heijna MH, Mulder AH.
    Eur J Pharmacol; 1988 Sep 13; 154(2):169-78. PubMed ID: 2906610
    [Abstract] [Full Text] [Related]

  • 11. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA, Lutz RA, Munson PJ, Rodbard D.
    J Pharmacol Exp Ther; 1987 Jul 13; 242(1):15-20. PubMed ID: 3039108
    [Abstract] [Full Text] [Related]

  • 12. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K, Lui GK, Pelton JT, Kazmierski W, Hruby VJ, Yamamura HI.
    NIDA Res Monogr; 1986 Jul 13; 75():209-12. PubMed ID: 2893264
    [Abstract] [Full Text] [Related]

  • 13. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    J Pharmacol Exp Ther; 1989 Jun 13; 249(3):864-8. PubMed ID: 2543814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan 13; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
    Kim KW, Cox BM.
    J Pharmacol Exp Ther; 1993 Dec 13; 267(3):1153-60. PubMed ID: 8263776
    [Abstract] [Full Text] [Related]

  • 18. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA, Marson L, Van Loon GR.
    J Pharmacol Exp Ther; 1989 Dec 13; 251(3):1096-103. PubMed ID: 2557411
    [Abstract] [Full Text] [Related]

  • 19. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 13; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 20. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun 13; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.